AWHL · Aspira Women's Health Inc.
$0.26
+0.00 (+0.00%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Given the above conditions, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated interim financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$12.21M
Shares
46.63M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$343K
+8475%
FY2025
Net Income
-$12.78M
+2.4%
FY2025
Gross Margin
1724.49%
-135250.5pp
FY2025
Operating Margin
-2307%
+404643pp
FY2025
Diluted EPS
-$0.37
+60.2%
FY2025
Operating Cash Flow
-$7.03M
+42%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $223K | $343K | $4000 | $87M | $8.18M | $6.81M | $4.65M | $4.54M | $3.05M | $3.12M | $2.64M | $2.18M | $2.52M | $2.57M | $2.09M | $1.92M | $1.18M | |
| -$472K | -$41K | -$33K | $48K | $17K | -$48K | $10K | $59K | -$22K | -$42K | -$28K | $28K | — | — | — | — | — | |
| $3.52M | $3.3M | $3.7M | $3.89M | $3.86M | $3.75M | $3.42M | $3.34M | $3.14M | $2.91M | $2.7M | $2.31M | $1.23M | $170K | $131K | $129K | $88K | |
| $5.02M | $5.92M | $5.48M | $5.26M | $4.32M | $3.06M | $1.24M | $1.2M | -$89K | $207K | -$56K | -$132K | $1.29M | $2.4M | $1.96M | $1.79M | $1.09M | |
| — | 1724.49% | 136975% | 6.05% | 52.82% | 44.95% | 26.57% | 26.33% | -2.92% | 6.63% | -2.12% | -6.06% | 51.21% | 93.37% | 93.74% | 93.29% | 92.51% | |
| $3.12M | $2.88M | $3.27M | $4.04M | $5.92M | $5.31M | $2.1M | $1.02M | $550K | $837K | $2.17M | $3.75M | $4.67M | $2.6M | $2.22M | $5.39M | $3.85M | |
| $2.33M | $2.99M | $8.15M | $7.81M | $14.92M | $17.09M | $8.84M | $9.65M | $5.64M | $4.27M | $6.8M | $9.83M | $9.89M | $4.48M | $4.65M | $5.54M | $2.86M | |
| $6.47M | $7.96M | $10.35M | $12.27M | $14.63M | $13.26M | $8.27M | $5.81M | $5.05M | $5.54M | $5.93M | $5.53M | $5.94M | $4.18M | $4.51M | $8.51M | $8.98M | |
| $139K | $75K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $168K | $112K | $92K | $199K | $264K | $302K | $265K | $333K | $675K | $786K | $723K | $291K | $141K | $72K | $86K | $77K | $114K | |
| $11.92M | $13.83M | $21.76M | $24.11M | $35.46M | $35.66M | $19.22M | $16.47M | $11.24M | $10.65M | $14.9M | $19.12M | $20.5M | $11.26M | $11.38M | $19.44M | $15.69M | |
| -$6.9M | -$7.91M | -$16.28M | -$18.85M | -$31.14M | -$32.6M | -$17.98M | -$15.28M | -$11.33M | -$10.44M | -$14.95M | -$19.25M | -$19.21M | -$8.86M | -$9.41M | -$17.64M | -$14.6M | |
| — | -2307% | -406950% | -21.67% | -380.47% | -478.49% | -386.61% | -336.67% | -371.21% | -334.54% | -566.01% | -884.2% | -762.04% | -345.4% | -449.57% | -917.37% | -1242.72% | |
| -$6.73M | -$7.8M | -$16.19M | -$18.65M | -$30.87M | -$32.29M | -$17.72M | -$14.95M | -$10.66M | -$9.66M | -$14.23M | -$18.96M | -$19.07M | -$8.79M | -$9.33M | -$17.56M | -$14.49M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $206K | $396K | $491K | |
| $22K | — | — | — | — | — | — | — | — | — | — | $28K | $40K | — | $28K | $64K | $40K | |
| -$3.1M | -$4.87M | $3.18M | $2.16M | $1.25M | $981K | $66K | -$18K | -$16K | -$14K | $14K | $106K | -$38K | $21K | -$182K | -$99K | $358K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $58K | |
| — | -$12.78M | -$13.09M | $16.69M | $29.9M | $31.66M | $17.91M | $15.24M | — | — | — | -$19.12M | -$19.21M | -$8.82M | -$7.15M | -$17.79M | -$19.03M | |
| — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | |
| -$10.01M | -$12.78M | -$13.09M | -$16.69M | -$29.89M | -$31.66M | -$17.91M | -$15.24M | -$11.37M | -$10.5M | -$14.97M | -$19.12M | -$19.21M | -$8.82M | -$7.15M | -$17.79M | -$19.03M | |
| — | -3725.95% | -327350% | -19.18% | -365.16% | -464.8% | -384.97% | -335.76% | -372.45% | -336.33% | -566.54% | -878.04% | -761.96% | -343.69% | -341.26% | -925.12% | -1619.91% | |
| — | — | — | — | -$29.89M | -$31.66M | -$17.91M | -$15.24M | -$11.37M | -$11.44M | -$14.97M | -$19.12M | -$19.21M | -$8.82M | -$7.15M | -$17.79M | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -$8.82M | -$6.99M | -$17.79M | — | |
| USD/shares | -$0.24 | -$0.37 | -$0.93 | -$1.81 | -$3.85 | -$4.27 | -$2.70 | -$2.70 | -$2.40 | -$3.00 | -$4.35 | -$6.15 | -$7.95 | -$6.30 | -$7.20 | — | — |
| USD/shares | -$0.31 | -$0.37 | -$0.93 | -$1.81 | -$3.85 | -$4.27 | -$2.70 | -$2.70 | -$2.40 | -$3.00 | -$4.35 | -$6.15 | -$7.95 | -$6.30 | -$7.20 | — | — |
| shares | — | 34.1M | 14.13M | 9.23M | 7.77M | 7.41M | 6.71M | 5.77M | 4.67M | 3.8M | 3.48M | 3.14M | 2.41M | 1.4M | 1M | 949.97K | — |
| shares | — | 34.1M | 14.13M | 9.23M | 7.77M | 7.41M | 6.71M | 5.77M | 4.67M | 3.8M | 3.48M | 3.14M | 2.41M | 1.4M | 1M | 949.97K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
60.28×
Diagnostics & Research median 4.34×
EV/EBIT
—
Diagnostics & Research median 33.46×
P/E (TTM)
—
Diagnostics & Research median 33.47×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Single Reportable Segment | $9,216,000 | $9,182,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Product | $9,216,000 | $9,182,000 | $9,153,000 | $7,970,000 | $6,568,000 | $4,543,000 |
| Genetics | — | — | $1,000 | $214,000 | $244,000 | $108,000 |